Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-09Neural Mechanisms of Anticholinergic Burden in Mid- to Late-Life Schizophrenia Spectrum
-
CLINICAL_TRIALS study record update · 2026-02-09Efficacy of a Dental Health Promotion Program in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-09A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dosed Phase II Clinical Study to Evaluate the Efficacy and Safety of LPM787000048 Maleate Extended-Release Tablets (LY03020) in Acutely Psychotic Adult Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-09Enhancing Prefrontal Oscillatory Activity and Working Memory Performance With Noninvasive Brain Stimulation in Early-course Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-06The Effectiveness and Efficacy of the Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective for Patients With Mental Health Disorders
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-06Comprehensive Treatment of Early Course Schizophrenia: A Nonrandomized Study of Long Acting Injectable Antipsychotic Medication Combined With Cognitive and Functional Skills Training
-
CLINICAL_TRIALS study record update · 2026-02-06Validation of Scale to Evaluate the Perception of Oral Health in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-06A Phase III Randomized, Double-blind, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Iclepertin Once Daily Over 26 Week Treatment Period in Patients With Schizophrenia (CONNEX-3)
-
CLINICAL_TRIALS study record update · 2026-02-06The Neuro-VR Study: A Pilot Study Investigating an Innovative Virtual Reality-based Intervention Employing Biofeedback to Increase Tolerability and Therapy Efficacy in Psychosis
-
CLINICAL_TRIALS study record update · 2026-02-06Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)
-
CLINICAL_TRIALS study record update · 2026-02-06A Randomized, Placebo-controlled, Double-blind Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacodynamics of SPG302 in Adult Participants Diagnosed With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-04Illness Management and Recovery (IMR) in Danish Community Mental Health Centres: Protocol of a Randomized, Assessor-blinded Multi-centre Clinical Trial of a Recovery-oriented Program for People With Schizophrenia or Bipolar Disorder
-
CLINICAL_TRIALS study record update · 2026-02-04A Long-term, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Flexible-Dose Brexpiprazole as Maintenance Treatment in Adolescents (13-17 Years Old) With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-03Transcranial Random Noise Stimulation in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients
-
CLINICAL_TRIALS study record update · 2026-02-03Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
-
CLINICAL_TRIALS study record update · 2026-02-03Magnetic Seizure Therapy for Schizophrenia - Trial
-
CLINICAL_TRIALS study record update · 2026-02-03Enhancing Recovery in Early Schizophrenia - a Multi-center, Two-arm, Double-blind, Randomized Phase II Trial Investigating Cannabidiol vs. Placebo as an add-on to an Individualized Antipsychotic Treatment
-
CLINICAL_TRIALS study record update · 2026-02-02Cognitive Enhancement for Persistent Negative Symptoms in Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-01-30Enhancing Rehabilitation for Veterans With Serious Mental Illness Via Biomarker-Informed Cognitive Training
-
CLINICAL_TRIALS study record update · 2026-01-29The Effect of Medication Education on Treatment Adherence and Side Effects in Psychiatric Inpatients: An Intervention Study
-
CLINICAL_TRIALS study record update · 2026-01-28Zyprexa® Relprevv™ Patient Care Program
-
CLINICAL_TRIALS study record update · 2026-01-28Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
-
CLINICAL_TRIALS study record update · 2026-01-27Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms
-
CLINICAL_TRIALS study record update · 2026-01-27Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE): a Community-Based Cognitive Remediation Trial
-
CLINICAL_TRIALS study record update · 2026-01-26THE EFFECT OF PSYCHOEDUCATION-BASED MOTIVATIONAL INTERVIEWING ON KNOWLEDGE ABOUT SCHIZOPHRENIA AND HOPE LEVELS IN PATIENTS DIAGNOSED WITH SCHIZOPHRENIA